IMARC Group, a leading market research company, has recently released a report titled "Peptide Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027". The study provides a detailed analysis of the industry, including the global peptide therapeutics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
What Are The Growth Prospects Of The Peptide Therapeutics Industry?
According to the report, The global peptide therapeutics market reached a value of US$ 35.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2027, exhibiting a CAGR of 9.42% during 2022-2027.
What is Peptide Therapeutics?
Peptide refers to the naturally occurring short versions of amino acids that benefit in the treatment of diseases by acting on the cell membrane. They are small, easy to synthesize, safe, well-tolerated, and have the ability to invade the cell membrane as compared to other treatment options. They offer anti-inflammatory properties and aid in enhancing the immune system, promoting tendon regeneration, and acting as an antioxidant for the treatment of numerous diseases. They also assist in treating prostate cancer among males and are utilized to slow down the aging process of skin. As a result, peptide therapeutics find extensive applications in treating metabolic, oncology, gastrointestinal, neurological, and cardiovascular disorders across the globe.
Request for a free sample copy of this report: https://www.imarcgroup.com/peptide-therapeutics-market/requestsample
What are the growth prospects and trends in the Peptide Therapeutics industry?
At present, the increasing prevalence of metabolic diseases and cancer among individuals around the world represents one of the key factors strengthening the market growth. In addition, the growing awareness about peptide therapeutics among consumers worldwide is offering a positive market outlook. Apart from this, the rising number of diseases among the geriatric population is propelling the growth of the market. Additionally, the wide availability of peptide therapeutics through various distribution channels, such as online and offline stores, is offering lucrative growth opportunities to industry investors. Furthermore, key players are introducing peptide drugs for the treatment of type 2 diabetes by enhancing insulin rates, which is supporting the growth of the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Type:
Breakup by Type of Manufacturer:
Breakup by Synthesis Technology:
- Solid Phase Peptide Synthesis
- Liquid Phase Peptide Synthesis
- Hybrid Technology
Breakup by Routes of Administration:
Breakup by Application:
- Gastrointestinal Disorders
- Neurological Disorders
- Metabolic Disorders
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Amgen Inc.
- Apitope International NV
- Arch Biopartners Inc.
- AstraZeneca plc
- Circle Pharma Inc.
- Corden Pharma GmbH
- F. Hoffmann-La Roche AG
- Ipsen Group
- Lonza Group AG
- Novo Nordisk A/S
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zealand Pharma A/S.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/peptide-therapeutics-market
Note:We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal